Muxiang Zhou
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Immunology top 10%
- Hematology top 5%
- Co-authors
- Lubing GuHarry W. FindleyNingxi ZhuLily YangWilliam G. WoodsFengzhi LiAndrew M. YeagerZehong Cao
- Topics
- Cancer-related Molecular Pathways (20 papers)Cell death mechanisms and regulation (18 papers)Cancer, Hypoxia, and Metabolism (6 papers)
- Cited by
- Cancer ResearchOncologyHematology
- Partner nations
- United StatesChinaCanada
In The Last Decade
Muxiang Zhou
51 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 1.6k
- Oncology 893
- Cancer Research 525
- Immunology 355
- Hematology 291
Countries citing papers authored by Muxiang Zhou
This map shows the geographic impact of Muxiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muxiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muxiang Zhou more than expected).
Fields of papers citing papers by Muxiang Zhou
This network shows the impact of papers produced by Muxiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muxiang Zhou. The network helps show where Muxiang Zhou may publish in the future.
Co-authorship network of co-authors of Muxiang Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Muxiang Zhou. A scholar is included among the top collaborators of Muxiang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muxiang Zhou. Muxiang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 24 | |
| 4 | 189 | |
| 5 | 23 | |
| 6 | 16 | |
| 7 | 40 | |
| 8 | 2 | |
| 9 | 39 | |
| 10 | 105 | |
| 11 | 47 | |
| 12 | 140 | |
| 13 | 1 | |
| 14 | 24 | |
| 15 | 29 | |
| 16 | 22 | |
| 17 | 38 | |
| 18 | Loss of PTEN expression induces NF-kB via PI3K/Akt pathway involving resistance to chemotherapy in acute lymphoblastic leukemia cell lines | 1 |
| 19 | 47 | |
| 20 | 48 |
About Muxiang Zhou
Muxiang Zhou is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 51 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (20 papers), Cell death mechanisms and regulation (18 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Cancer Research (525 citations), Oncology (893 citations) and Hematology (291 citations). Muxiang Zhou has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Lubing Gu, Harry W. Findley, Ningxi Zhu, Lily Yang, William G. Woods, Fengzhi Li, Andrew M. Yeager, Zehong Cao, Bing‐Hua Jiang and Prasanthi Karna. Their work appears in journals such as Nature, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.